FDA
-
25 Aug
Are FDA expedited drug reviews delivering rapid health benefits or unnecessary risks?
The FDA has been on the right track when taking forward promising pipeline drugs for expedited new drug application (NDA) review.
-
28 Jun
Sanofi is about to explode into the global dermatology market
Over the next few years Sanofi will go from being an also-ran in the dermatology arena to being a major player, thanks to the performance of a groundbreaking new drug.
-
31 Jan
Superbugs will kill 10m people per year by 2050 unless things change
Drug-resistant so-called superbugs kill at least 700,000 worldwide each year and deaths are expected to rise to 10m per year by 2050, according to economist Jim O’Neill.